Researchers identify diabetes drug metformin as potential atrial fibrillation treatment in collaborative research
Researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation. They used advanced computation and genetic sequencing to determine that metformin’s targets overlap significantly with genes dysregulated in atrial fibrillation.
Read Original Article: Researchers identify diabetes drug metformin as potential atrial fibrillation treatment in collaborative research »
